The world of probiotics is undergoing a paradigm shift, and the future lies in an intriguing blend of traceability and functionality. This evolution was highlighted by Lucas Chang, R&D Manager at TCI, during his presentation at the Growth Asia Summit 2026. Chang emphasized that the focus has shifted from mere logistics to understanding the biological intricacies.
In the past, probiotic delivery was straightforward: protect the microbes, ensure their survival, and release them into the intestine. But Chang argues that this is just the beginning. The real challenge lies in what happens post-delivery, and this is where the concept of traceability becomes crucial.
"The real advance in gut-axis science is not just drawing connections but tracing biology," Chang explained. This means that the entire chain of events, from microbiome function to host response and measurable impact, must be traceable. It's about understanding the intricate dance of biology, not just the correlation.
This shift in perspective is particularly relevant when discussing healthy aging. Aging is not a linear decline; it's a series of pressure points and transitions. Chang cited a longitudinal study that revealed two critical checkpoints in our lifespan: around the age of 40 and 60. During these transitions, the body undergoes significant disruptions, affecting lipid metabolism, alcohol metabolism, immune regulation, and more.
"Healthy aging is about resilience," Chang said. "It's about how well our bodies can handle these biological challenges and recover in time for the next one."
TCI's approach to tackling these challenges is innovative. They developed TCR711, a patented probiotic strain, to target two common aging stresses: fat accumulation and alcohol. In a randomized study, TCR711 showed an impressive 8.7% improvement in liver-fat outcome for adults with non-alcoholic fatty liver disease. The study also suggested that the probiotic's impact extended beyond the liver, influencing the gut ecosystem and microbial metabolic capacity.
In another study, TCR711 demonstrated its ability to enhance alcohol clearance, with detectable changes in alcohol dehydrogenase and aldehyde dehydrogenase-related capabilities.
But what makes TCI's approach truly unique is their focus on functional delivery. Chang emphasized that engineering a functional probiotic is about more than just survival; it's about ensuring the probiotic strain does a specific job.
"We start with the desired health outcome and trace the biology backward," Chang explained. "Then, we build the probiotic strain, function, and delivery around it."
This innovative thinking led to the development of a liquid probiotic chocolate. Chang believes that sometimes the answer to advanced probiotic delivery lies not in forcing probiotics into supplement formats but in leveraging everyday foods.
"It's about building daily habits and creating a strain-compatible environment," he said.
The future of probiotics is an exciting frontier, and TCI's work showcases the potential for innovative solutions. As we continue to explore the gut-axis and its impact on healthy aging, the focus on traceability and functionality will undoubtedly shape the next generation of probiotic advancements.
